Skip to content
Screener

Silgan Holdings SLGN Property, plant, and equipment additions

Property, plant, and equipment additions at other companies

Constellium logo
ConstelliumCSTM
$71M-2.7%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Segments

By segment

See full
Dispensing and Specialty Closures$36.35M-25.4%
Metal Containers$21.21M+19.6%
Custom Containers$6.68M+14.7%

Other financials

Income statement

See full
Revenue$1.6B+6.8%
Gross profit$294.9M-1.4%
Net income$75.8M-14.8%
EPS (diluted)$0.72-13.3%

Balance sheet

See full
Cash & equivalents$351.5M+10.7%
Total debt$6.0B-13.9%
Total equity$2.4B+7.1%
Total assets$9.6B+2.0%

Cash flow

See full
Operating cash flow-$194.3M+12.3%
CapEx$64.2M-11.7%
Free cash flow-$258.5M+12.1%

Valuation

See full
Market cap$4.41B-11.0%
Enterprise value$10.08B-13.3%
P/E16.3×-0.1×
P/S0.7×-0.1×

Profitability

See full
Gross margin17.1%-0.8pp
Operating margin8.7%
Net margin4%-0.9pp
FCF margin5.1%+4.2pp

Returns & leverage

See full
Return on equity11.7%-2.8pp
Debt / equity2.5×-0.6×
Current ratio1.3×+0.3×